JP2021530971A5 - - Google Patents
Info
- Publication number
- JP2021530971A5 JP2021530971A5 JP2020571816A JP2020571816A JP2021530971A5 JP 2021530971 A5 JP2021530971 A5 JP 2021530971A5 JP 2020571816 A JP2020571816 A JP 2020571816A JP 2020571816 A JP2020571816 A JP 2020571816A JP 2021530971 A5 JP2021530971 A5 JP 2021530971A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- her2
- tac
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862699173P | 2018-07-17 | 2018-07-17 | |
| US62/699,173 | 2018-07-17 | ||
| US201862703037P | 2018-07-25 | 2018-07-25 | |
| US62/703,037 | 2018-07-25 | ||
| US201862773120P | 2018-11-29 | 2018-11-29 | |
| US62/773,120 | 2018-11-29 | ||
| US201962826853P | 2019-03-29 | 2019-03-29 | |
| US62/826,853 | 2019-03-29 | ||
| US201962828879P | 2019-04-03 | 2019-04-03 | |
| US62/828,879 | 2019-04-03 | ||
| US201962839235P | 2019-04-26 | 2019-04-26 | |
| US62/839,235 | 2019-04-26 | ||
| US16/442,274 | 2019-06-14 | ||
| US16/442,274 US10640562B2 (en) | 2018-07-17 | 2019-06-14 | T cell-antigen coupler with various construct optimizations |
| US201962874426P | 2019-07-15 | 2019-07-15 | |
| US62/874,426 | 2019-07-15 | ||
| PCT/US2019/042297 WO2020018727A1 (en) | 2018-07-17 | 2019-07-17 | T cell-antigen coupler with various construct optimizations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530971A JP2021530971A (ja) | 2021-11-18 |
| JP2021530971A5 true JP2021530971A5 (enExample) | 2022-07-14 |
| JP7404279B2 JP7404279B2 (ja) | 2023-12-25 |
Family
ID=69163917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020571816A Active JP7404279B2 (ja) | 2018-07-17 | 2019-07-17 | 様々な構築物最適化を備えたｔ細胞抗原カプラ |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3823984A4 (enExample) |
| JP (1) | JP7404279B2 (enExample) |
| KR (1) | KR102834084B1 (enExample) |
| CN (1) | CN112689642B (enExample) |
| AU (1) | AU2019307905B2 (enExample) |
| BR (1) | BR112021000735A2 (enExample) |
| CA (1) | CA3104887A1 (enExample) |
| IL (1) | IL280049A (enExample) |
| MX (1) | MX2021000541A (enExample) |
| PH (1) | PH12021550114A1 (enExample) |
| SG (1) | SG11202100307WA (enExample) |
| WO (1) | WO2020018727A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2959480T3 (es) | 2014-02-07 | 2024-02-26 | Univ Mcmaster | Acoplador de células T - antígeno trifuncional y métodos y usos del mismo |
| EP3694997A4 (en) | 2017-10-12 | 2021-06-30 | Mcmaster University | T cell-antigen coupler with y182t mutation and methods and uses thereof |
| US11110123B2 (en) | 2018-07-17 | 2021-09-07 | Triumvira Immunologics Usa, Inc. | T cell-antigen coupler with various construct optimizations |
| US10640562B2 (en) | 2018-07-17 | 2020-05-05 | Mcmaster University | T cell-antigen coupler with various construct optimizations |
| EP4326889A2 (en) | 2021-04-21 | 2024-02-28 | Conagen Inc. | Biosynthetic production of delta-lactones using cytochrome p450 hydroxylase enzymes or mutants thereof |
| AU2022283819A1 (en) * | 2021-06-01 | 2024-01-04 | Triumvira Immunologics Usa, Inc. | Claudin 18.2 t cell-antigen couplers and uses thereof |
| US11453723B1 (en) | 2021-06-25 | 2022-09-27 | Mcmaster University | BCMA T cell-antigen couplers and uses thereof |
| CN115820698B (zh) * | 2022-11-22 | 2025-01-21 | 浙江康佰裕生物科技有限公司 | 含有嵌合抗原受体和嵌合转换开关受体编码基因的融合基因及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104203981A (zh) * | 2011-12-19 | 2014-12-10 | 合成免疫股份有限公司 | 双特异性抗体分子 |
| KR20150029714A (ko) * | 2012-07-13 | 2015-03-18 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 이중특이적 항체의 공-도입에 의한 ｃａｒ 세포의 활성 증강 |
| ES2959480T3 (es) * | 2014-02-07 | 2024-02-26 | Univ Mcmaster | Acoplador de células T - antígeno trifuncional y métodos y usos del mismo |
| PL3280729T3 (pl) * | 2015-04-08 | 2022-08-22 | Novartis Ag | Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19 |
| WO2016166139A1 (en) * | 2015-04-14 | 2016-10-20 | Eberhard Karls Universität Tübingen | Bispecific fusion proteins for enhancing immune responses of lymphocytes against tumor cells |
| CA3030003A1 (en) * | 2016-07-08 | 2018-01-11 | F1 Oncology, Inc. | Methods and compositions for transducing lymphocytes and regulating the activity thereof |
| EP3493827A4 (en) | 2016-08-04 | 2020-02-26 | Memorial Sloan-Kettering Cancer Center | COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY |
| CN108250302A (zh) * | 2016-12-29 | 2018-07-06 | 天津天锐生物科技有限公司 | 一种多功能蛋白质 |
-
2019
- 2019-07-17 CN CN201980047935.6A patent/CN112689642B/zh active Active
- 2019-07-17 JP JP2020571816A patent/JP7404279B2/ja active Active
- 2019-07-17 AU AU2019307905A patent/AU2019307905B2/en active Active
- 2019-07-17 MX MX2021000541A patent/MX2021000541A/es unknown
- 2019-07-17 KR KR1020217004572A patent/KR102834084B1/ko active Active
- 2019-07-17 SG SG11202100307WA patent/SG11202100307WA/en unknown
- 2019-07-17 BR BR112021000735-0A patent/BR112021000735A2/pt not_active Application Discontinuation
- 2019-07-17 EP EP19838648.4A patent/EP3823984A4/en active Pending
- 2019-07-17 CA CA3104887A patent/CA3104887A1/en active Pending
- 2019-07-17 WO PCT/US2019/042297 patent/WO2020018727A1/en not_active Ceased
-
2021
- 2021-01-10 IL IL280049A patent/IL280049A/en unknown
- 2021-01-15 PH PH12021550114A patent/PH12021550114A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022017333A5 (enExample) | ||
| JP2024522357A5 (enExample) | ||
| FI3599251T3 (fi) | Cd20-antigeeniin kohdentuvan kimeerisen antigeenireseptorin rakentaminen ja sillä muunnettujen t-solujen aktiivisuuden tunnistaminen | |
| IL259120A (en) | Her2-targeted antigen chimeric receptors2 | |
| JP2008056679A5 (enExample) | ||
| RU2020127887A (ru) | Полипептиды транспозазы и их применение | |
| PH12020550600A1 (en) | Novel engineered t cell receptors and immune therapy using the same | |
| JP2017160222A5 (enExample) | ||
| JP2014088414A5 (enExample) | ||
| JP2020500523A5 (enExample) | ||
| JP2019536426A5 (enExample) | ||
| JP2017523184A5 (enExample) | ||
| JP2013513377A5 (enExample) | ||
| RU2016146389A (ru) | Улучшенные полиэтилениминовые полиэтиленгликолевые векторы | |
| JP2021501567A5 (enExample) | ||
| CN114592010A (zh) | NK-CAR-MbIL-15细胞及其制备方法和应用 | |
| JP2022512538A5 (enExample) | ||
| WO2015172563A1 (zh) | 一种靶向eps8与egfr结合的短肽及其应用 | |
| CN115232217B (zh) | 一种SynNotch结构及其应用 | |
| Wang et al. | Placental targeted drug delivery: a review of recent progress | |
| Aljabali et al. | The dual promise of oncolytic viruses: selective targeting and therapeutic enhancement in cancer treatment | |
| RU2020100072A (ru) | Иммуногенные композиции, содержащие cea, muc1 и tert | |
| JP2020526202A5 (enExample) | ||
| JP2021505190A5 (enExample) | ||
| MX2025015364A (es) | Proteinas de union al antigeno contra el peptido antigenico b2 asociado al melanoma expresado en tumores (mageb2) |